---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-005633"
form_type: "8-K"
ticker: "PCSA"
cik: "0001533743"
company_name: "Processa Pharmaceuticals, Inc."
filed_at: "2025-02-10T23:59:59+00:00"
generated_at: "2026-05-27T00:00:11.078741+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Processa receives Nasdaq bid-price deficiency notice; 180 days to regain compliance

## Summary
- Nasdaq notified Processa that common stock bid price closed below $1.00 for 30 consecutive business days.
- Company has until August 4, 2025 to regain compliance by closing at $1.00 or more for 10 consecutive days.
- If not compliant by deadline, may qualify for a second 180-day period or face potential delisting.
- Stock continues trading under symbol PCSA on Nasdaq Capital Market during cure period.

## SEC filing metadata
- accession: 0001493152-25-005633
- form_type: 8-K
- ticker: PCSA
- cik: 0001533743
- company_name: Processa Pharmaceuticals, Inc.
- filed_at: 2025-02-10T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533743/000149315225005633/0001493152-25-005633-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533743/000149315225005633/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-005633
- JSON: https://secwatch.observer/filing/0001493152-25-005633.json
- Plain text: https://secwatch.observer/filing/0001493152-25-005633.txt

## Source-grounded claims
- claim_id: 68ae8d93894ef913b418587833a79602ac057cb4
  claim: Processa Pharmaceuticals, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  evidence_excerpt: February 4, 2025, Processa Pharmaceuticals, Inc. (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company t
  evidence_url: https://www.sec.gov/Archives/edgar/data/1533743/000149315225005633/0001493152-25-005633-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.